Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.44 -0.04 (-0.38%) As of 05/21/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. NXRT, ABL, TINV, USAR, AC, ORC, PAX, PLYM, GETY, and AACTShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include NexPoint Residential Trust (NXRT), Abacus Life (ABL), Tiga Acquisition (TINV), USA Rare Earth (USAR), Associated Capital Group (AC), Orchid Island Capital (ORC), Patria Investments (PAX), Plymouth Industrial REIT (PLYM), Getty Images (GETY), and Ares Acquisition Co. II (AACT). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. NexPoint Residential Trust Abacus Life Tiga Acquisition USA Rare Earth Associated Capital Group Orchid Island Capital Patria Investments Plymouth Industrial REIT Getty Images Ares Acquisition Co. II NexPoint Residential Trust (NYSE:NXRT) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation. Does the MarketBeat Community believe in NXRT or OACC? NexPoint Residential Trust received 204 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformNexPoint Residential TrustOutperform Votes20456.20% Underperform Votes15943.80% Oaktree Acquisition Corp. III Life SciencesN/AN/A Which has higher valuation and earnings, NXRT or OACC? NexPoint Residential Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexPoint Residential Trust$255.34M3.42$44.26M-$1.28-27.02Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A Do analysts prefer NXRT or OACC? NexPoint Residential Trust currently has a consensus price target of $44.25, indicating a potential upside of 27.95%. Given NexPoint Residential Trust's stronger consensus rating and higher possible upside, equities research analysts clearly believe NexPoint Residential Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexPoint Residential Trust 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor NXRT or OACC? In the previous week, NexPoint Residential Trust had 9 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 13 mentions for NexPoint Residential Trust and 4 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.67 beat NexPoint Residential Trust's score of 0.98 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexPoint Residential Trust 10 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oaktree Acquisition Corp. III Life Sciences 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals & insiders have more ownership in NXRT or OACC? 76.6% of NexPoint Residential Trust shares are held by institutional investors. 15.4% of NexPoint Residential Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is NXRT or OACC more profitable? NexPoint Residential Trust has a net margin of 17.54% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. NexPoint Residential Trust's return on equity of 9.54% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets NexPoint Residential Trust17.54% 9.54% 2.29% Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A SummaryNexPoint Residential Trust beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesHolding Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$235.01M$477.17M$5.33B$8.39BDividend YieldN/A7.55%4.18%4.10%P/E RatioN/A2.5312.7919.71Price / SalesN/A70.721,736.81117.54Price / CashN/A69.0149.7134.62Price / BookN/A6.841.344.50Net IncomeN/A$35.22M$1.22B$248.18M7 Day Performance-0.19%0.45%0.46%0.23%1 Month Performance3.67%3.32%11.18%12.39%1 Year PerformanceN/A24.62%13.07%7.07% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.44-0.4%N/AN/A$235.01MN/A0.00N/ANews CoveragePositive NewsHigh Trading VolumeNXRTNexPoint Residential Trust4.925 of 5 stars$36.96+1.3%$44.25+19.7%-5.2%$934.48M$255.34M21.123Analyst ForecastABLAbacus Life3.0864 of 5 stars$8.91-0.6%$14.08+58.1%-25.2%$862.96M$111.92M-49.5082Analyst RevisionTINVTiga AcquisitionN/A$23.51-2.4%N/A+154.6%$811.10MN/A0.00N/AHigh Trading VolumeUSARUSA Rare EarthN/A$9.77+3.3%N/AN/A$800.67MN/A0.00N/AACAssociated Capital Group3.2376 of 5 stars$37.27-0.9%N/A+11.2%$788.27M$13.18M18.0020ORCOrchid Island Capital4.4668 of 5 stars$7.18+0.4%$9.50+32.3%-20.2%$784.42M$52.24M11.972,018Positive NewsPAXPatria Investments2.8011 of 5 stars$12.85+1.8%$14.00+8.9%-3.1%$768.01M$374.20M25.70390Positive NewsGap UpPLYMPlymouth Industrial REIT3.0182 of 5 stars$16.54-0.2%$21.10+27.5%-24.5%$753.55M$193.70M827.2040GETYGetty Images3.2724 of 5 stars$1.81+2.6%$4.35+141.0%-52.9%$746.22M$941.09M15.041,700AACTAres Acquisition Co. IIN/A$11.29+0.0%N/A+6.1%$705.31MN/A0.00N/APositive NewsHigh Trading Volume Related Companies and Tools Related Companies NexPoint Residential Trust Competitors Abacus Life Competitors Tiga Acquisition Competitors USA Rare Earth Competitors Associated Capital Group Competitors Orchid Island Capital Competitors Patria Investments Competitors Plymouth Industrial REIT Competitors Getty Images Competitors Ares Acquisition Co. II Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
